| Comorbidities of COPD A Cavaillès, G Brinchault-Rabin, A Dixmier, F Goupil, C Gut-Gobert, ... European Respiratory Review 22 (130), 454-475, 2013 | 755 | 2013 |
| Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020 | 510 | 2020 |
| Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis N Riteau, P Gasse, L Fauconnier, A Gombault, M Couegnat, L Fick, ... American journal of respiratory and critical care medicine 182 (6), 774-783, 2010 | 493 | 2010 |
| MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ... New England Journal of Medicine 379 (23), 2209-2219, 2018 | 471 | 2018 |
| Pulmonary manifestations of Sjögren's syndrome T Flament, A Bigot, B Chaigne, H Henique, E Diot, S Marchand-Adam European Respiratory Review 25 (140), 110-123, 2016 | 325 | 2016 |
| Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study M Humbert, C Taillé, L Mala, V Le Gros, J Just, M Molimard, M Agossou, ... European Respiratory Journal 51 (5), 2018 | 297 | 2018 |
| Physiology of the lung in idiopathic pulmonary fibrosis L Plantier, A Cazes, AT Dinh-Xuan, C Bancal, S Marchand-Adam, ... European Respiratory Review 27 (147), 2018 | 256 | 2018 |
| Methotrexate and rheumatoid arthritis associated interstitial lung disease PA Juge, JS Lee, J Lau, L Kawano-Dourado, JR Serrano, M Sebastiani, ... European Respiratory Journal 57 (2), 2021 | 228 | 2021 |
| Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis J Marchal-Sommé, Y Uzunhan, S Marchand-Adam, D Valeyre, ... The Journal of Immunology 176 (10), 5735-5739, 2006 | 218 | 2006 |
| Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis PA Juge, R Borie, C Kannengiesser, S Gazal, P Revy, ... European Respiratory Journal 49 (5), 2017 | 217 | 2017 |
| Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d'Etudes et de Recherche sur les … V Cottin, E Bel, P Bottero, K Dalhoff, M Humbert, R Lazor, RA Sinico, ... Autoimmunity reviews 16 (1), 1-9, 2017 | 193 | 2017 |
| Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis L Sesé, H Nunes, V Cottin, S Sanyal, M Didier, Z Carton, D Israel-Biet, ... Thorax 73 (2), 145-150, 2018 | 192 | 2018 |
| Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis R Borie, L Tabèze, G Thabut, H Nunes, V Cottin, S Marchand-Adam, ... European Respiratory Journal 48 (6), 1721-1731, 2016 | 170 | 2016 |
| Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) V Cottin, E Bel, P Bottero, K Dalhoff, M Humbert, R Lazor, RA Sinico, ... European Respiratory Journal 48 (5), 1429-1441, 2016 | 160 | 2016 |
| Women and COPD: do we need more evidence? C Gut-Gobert, A Cavaillès, A Dixmier, S Guillot, S Jouneau, C Leroyer, ... European Respiratory Review 28 (151), 2019 | 154 | 2019 |
| Therapeutic targeting of cathepsin C: from pathophysiology to treatment B Korkmaz, GH Caughey, I Chapple, F Gauthier, J Hirschfeld, DE Jenne, ... Pharmacology & therapeutics 190, 202-236, 2018 | 138 | 2018 |
| Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice A Fabre, J Marchal-Sommé, S Marchand-Adam, C Quesnel, R Borie, ... European Respiratory Journal 32 (2), 426-436, 2008 | 133 | 2008 |
| Dendritic cells accumulate in human fibrotic interstitial lung disease J Marchal-Sommé, Y Uzunhan, S Marchand-Adam, M Kambouchner, ... American journal of respiratory and critical care medicine 176 (10), 1007-1014, 2007 | 132 | 2007 |
| Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study CH Marquette, J Boutros, J Benzaquen, M Ferreira, J Pastre, C Pison, ... The Lancet Respiratory Medicine 8 (7), 709-716, 2020 | 127 | 2020 |
| B cell activating factor is central to bleomycin-and IL-17-mediated experimental pulmonary fibrosis A François, A Gombault, B Villeret, G Alsaleh, M Fanny, P Gasse, ... Journal of autoimmunity 56, 1-11, 2015 | 116 | 2015 |
